Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of Immunoprotective Effects of DNA Vaccine Based on <i>Eimeria maxima</i> EF-1α Antigen and Chicken XCL1 Chemokine.

Animals : an open access journal from MDPI·2026
Same author

Latent profile analysis of kinesiophobia during the out-of-hospital early rehabilitation phase after PCI in patients with CHD.

Scientific reports·2026
Same author

Protocol for combining BMP, MEK, WNT inhibition and iNGN2 to enable rapid neuronal differentiation and regional patterning from hiPSCs.

STAR protocols·2026
Same author

The neuronal ALAS2/5-ala axis mitigates chemotherapy-induced neurotoxicity via the BACH1/NRF2 pathway.

British journal of pharmacology·2026
Same author

Counting cells can accurately predict small-molecule bioactivity benchmarks.

Nature communications·2026
Same author

Dominant-negative TP53 mutations potentiated by the HSF1-regulated proteostasis network.

Molecular cell·2026
Same journal

Bioactive carbon dots from peony seed meal for nanomedicine via circular economy.

iScience·2026
Same journal

Genetic ablation of <i>Sfxn5</i> induces mitochondrial dysfunction and precipitates lethal metabolic crisis in mice.

iScience·2026
Same journal

Expansion, functional diversification, and gene fusion events in the Ato protein family.

iScience·2026
Same journal

The pro-inflammatory cytokines IFN-α and TNF-α inhibit organoid-derived extravillous trophoblast invasion.

iScience·2026
Same journal

Urbanization compound pathways of global lung cancer incidence risk under proximal and distal interactions.

iScience·2026
Same journal

Capsid and integrase play essential apposing roles in viral ribonucleoprotein assembly during HIV-1 core morphogenesis.

iScience·2026
See all related articles

Related Experiment Video

Updated: Jun 23, 2026

Vibrodissociation of Neurons from Rodent Brain Slices to Study Synaptic Transmission and Image Presynaptic Terminals
08:38

Vibrodissociation of Neurons from Rodent Brain Slices to Study Synaptic Transmission and Image Presynaptic Terminals

Published on: May 25, 2011

SynCAR platform for capturing neuronal synaptic proteopathic seeds.

Rebecca M Sebastian1, Robert Kupp2, Dhaval Nanavati3

  • 1AbbVie, Cambridge Research Center, 200 Sidney Street, Cambridge, MA 02139, USA.

Iscience
|June 22, 2026
PubMed
Summary
This summary is machine-generated.

Researchers developed a novel synaptic chimeric antigen receptor (synCAR) to capture and study synaptic proteins. This tool aids in understanding neurodegenerative diseases like Alzheimer's by targeting pathological tau species.

Keywords:
Cell biologyMolecular biologyNeuroscience

More Related Videos

Preparation of Synaptoneurosomes from Mouse Cortex using a Discontinuous Percoll-Sucrose Density Gradient
08:30

Preparation of Synaptoneurosomes from Mouse Cortex using a Discontinuous Percoll-Sucrose Density Gradient

Published on: September 17, 2011

Microtransplantation of Synaptic Membranes to Reactivate Human Synaptic Receptors for Functional Studies
10:08

Microtransplantation of Synaptic Membranes to Reactivate Human Synaptic Receptors for Functional Studies

Published on: July 20, 2022

Related Experiment Videos

Last Updated: Jun 23, 2026

Vibrodissociation of Neurons from Rodent Brain Slices to Study Synaptic Transmission and Image Presynaptic Terminals
08:38

Vibrodissociation of Neurons from Rodent Brain Slices to Study Synaptic Transmission and Image Presynaptic Terminals

Published on: May 25, 2011

Preparation of Synaptoneurosomes from Mouse Cortex using a Discontinuous Percoll-Sucrose Density Gradient
08:30

Preparation of Synaptoneurosomes from Mouse Cortex using a Discontinuous Percoll-Sucrose Density Gradient

Published on: September 17, 2011

Microtransplantation of Synaptic Membranes to Reactivate Human Synaptic Receptors for Functional Studies
10:08

Microtransplantation of Synaptic Membranes to Reactivate Human Synaptic Receptors for Functional Studies

Published on: July 20, 2022

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Synaptic proteins are crucial for neuronal function but implicated in the spread of neurodegenerative diseases.
  • Existing technologies face limitations in identifying synaptic proteins in situ.
  • Pathological proteins, like tau in Alzheimer's disease, can spread between synapses.

Purpose of the Study:

  • To develop a novel tool for the in situ identification and modulation of synaptic proteins.
  • To investigate the role of synaptic proteins in the prion-like spreading of pathological tau.
  • To establish a platform for neurodegenerative disease research and drug development.

Main Methods:

  • Construction of a modular synaptic chimeric antigen receptor (synCAR) by fusing a single-chain antibody fragment with neurolignin-1 (NLGN1).
  • Application of the synCAR platform to capture pathogenic tau species at the synapse using the PHF1 antibody.
  • Expression of the PHF1 synCAR in mouse primary and human neuronal tau seeding models.

Main Results:

  • The synCAR platform successfully captured pathogenic synaptic tau species.
  • Anchoring the tau antibody PHF1 to the synapse via synCAR enhanced tau aggregation.
  • Concentration of pathological tau seeds at the synapse by synCAR likely increased aggregation.

Conclusions:

  • The study presents the first method for isolating and modulating synaptic protein function in situ.
  • The synCAR platform is a valuable tool for synaptic protein research.
  • SynCAR technology holds promise for neurodegenerative disease drug development, particularly for Alzheimer's disease.